185 related articles for article (PubMed ID: 34797367)
1. Influenza Vaccine Uptake in the Year After Concurrent vs Separate Influenza and Zoster Immunization.
Rome BN; Feldman WB; Fischer MA; Desai RJ; Avorn J
JAMA Netw Open; 2021 Nov; 4(11):e2135362. PubMed ID: 34797367
[TBL] [Abstract][Full Text] [Related]
2. Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017.
Shen AK; Warnock R; Selna W; MaCurdy TE; Chu S; Kelman JA
Vaccine; 2019 Feb; 37(9):1194-1201. PubMed ID: 30683507
[TBL] [Abstract][Full Text] [Related]
3. Vaccination coverage and predictors of influenza, pneumococcal, herpes zoster, tetanus, measles, and hepatitis B vaccine uptake among adults in Greece.
Tsiligianni I; Bouloukaki I; Papazisis G; Paganas A; Chatzimanolis E; Kalatharas M; Platakis I; Tirodimos I; Dardavesis T; Tsimtsiou Z
Public Health; 2023 Nov; 224():195-202. PubMed ID: 37820537
[TBL] [Abstract][Full Text] [Related]
4. An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability.
La EM; Trantham L; Kurosky SK; Odom D; Aris E; Hogea C
Hum Vaccin Immunother; 2018 Feb; 14(2):430-441. PubMed ID: 29194019
[TBL] [Abstract][Full Text] [Related]
5. Assessing and Improving Zoster Vaccine Uptake in a Homeless Population.
Kaplan-Weisman L; Waltermaurer E; Crump C
J Community Health; 2018 Dec; 43(6):1019-1027. PubMed ID: 29730833
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine.
Akpandak I; Miller DC; Sun Y; Arnold BF; Kelly JD; Acharya NR
JAMA Netw Open; 2022 Nov; 5(11):e2242240. PubMed ID: 36383382
[TBL] [Abstract][Full Text] [Related]
7. Costs of adult vaccination in medical settings and pharmacies: an observational study.
Singhal PK; Zhang D
J Manag Care Spec Pharm; 2014 Sep; 20(9):930-6. PubMed ID: 25166292
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine.
Levin MJ; Buchwald UK; Gardner J; Martin J; Stek JE; Brown E; Popmihajlov Z
Vaccine; 2018 Jan; 36(1):179-185. PubMed ID: 28830693
[TBL] [Abstract][Full Text] [Related]
9. Shingles Vaccination Among Adults Aged 60 and Over: United States, 2018.
Terlizzi EP; Black LI
NCHS Data Brief; 2020 Jul; (370):1-8. PubMed ID: 32730737
[TBL] [Abstract][Full Text] [Related]
10. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.
Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR
JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for older adults.
Lam S; Jodlowski TZ
Consult Pharm; 2009 May; 24(5):380-91. PubMed ID: 19555147
[TBL] [Abstract][Full Text] [Related]
12. Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study.
Hawkins KL; Gordon KS; Levin MJ; Weinberg A; Battaglia C; Rodriguez-Barradas MC; Brown ST; Rimland D; Justice A; Tate J; Erlandson KM;
J Acquir Immune Defic Syndr; 2018 Dec; 79(4):527-533. PubMed ID: 30179984
[TBL] [Abstract][Full Text] [Related]
13. Receipt of other routinely recommended vaccines relative to receipt of seasonal influenza vaccines: Trends from medicare administrative data, 2013-2015.
Shen AK; Warnock R; Chu S; Kelman JA
Vaccine; 2018 Jul; 36(30):4399-4403. PubMed ID: 29909132
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of influenza, pneumococcal and herpes zoster vaccination coverage in Australian aged care residents, 2018 to 2022.
Bennett N; Morris B; Malloy MJ; Lim LL; Watson E; Bull A; Sluggett J; Worth LJ;
Infect Dis Health; 2023 Nov; 28(4):253-258. PubMed ID: 37147271
[TBL] [Abstract][Full Text] [Related]
15. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
[TBL] [Abstract][Full Text] [Related]
16. Physician Attitudes Toward Adult Vaccines and Other Preventive Practices, United States, 2012.
Hurley LP; Bridges CB; Harpaz R; Allison MA; O' Leary ST; Crane LA; Brtnikova M; Stokley S; Beaty BL; Jimenez-Zambrano A; Kempe A
Public Health Rep; 2016; 131(2):320-30. PubMed ID: 26957667
[TBL] [Abstract][Full Text] [Related]
17. [Analysis on vaccination willingness and related factors of influenza, pneumonia, and herpes zoster vaccine among people over 50 years old in Minhang district of Shanghai].
Lu J; Lu XY; Shen YT; Zhang LP; Mei KW; Guan BC; Lu YH
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Feb; 56(2):125-131. PubMed ID: 35184439
[No Abstract] [Full Text] [Related]
18. Impact of implementing a technology platform in community pharmacies to increase adult immunizations rates.
Wehbi NK; Wani RJ; Klepser DG; Murry J; Khan AS
Vaccine; 2019 Jan; 37(1):56-60. PubMed ID: 30471954
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States.
Lu A; Sun Y; Porco TC; Arnold BF; Acharya NR
Ophthalmology; 2021 Dec; 128(12):1699-1707. PubMed ID: 33892049
[TBL] [Abstract][Full Text] [Related]
20. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease.
Tseng HF; Smith N; Harpaz R; Bialek SR; Sy LS; Jacobsen SJ
JAMA; 2011 Jan; 305(2):160-6. PubMed ID: 21224457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
